Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue

British Journal of Haematology

Volumn 144, Issue 1, 2009, Pages 99-106

  Larsen, Ole H ^a   Clausen, Niels ^a   Persson, Egon ^b   Ezban, Mirella ^b   Ingerslev, Jørgen ^a   Sørensen, Benny ^a,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Platelet aggregation; Recombinant factor VIIa; Recombinant factor VIIa analogue; Thrombelastography; Thrombocytopenia

Indexed keywords

GENTAMICIN; NN 1731; PIPERACILLIN PLUS TAZOBACTAM; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; MALE; PRIORITY JOURNAL; THROMBIN TIME; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY; TREATMENT RESPONSE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FACTOR VII; FACTOR VIIA; FEMALE; HEMOSTATICS; HUMANS; INFANT; MALE; PLATELET AGGREGATION; RECOMBINANT PROTEINS; THROMBELASTOGRAPHY; THROMBIN; THROMBOCYTOPENIA; TREATMENT OUTCOME; WHOLE BLOOD COAGULATION TIME;

EID: 57449094975     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07439.x     Document Type: Article

References (33)

1. Allen, G.A., Persson, E., Campbell, R.A., Ezban, M., Hedner, U. Wolberg, A.S. (2007) A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 683 689.
2. Avvisati, G., Tirindelli, M.C. Annibali, O. (2003) Thrombocytopenia and hemorrhagic risk in cancer patients. Critical Reviews in Oncology/Hematology, 48, S13 S16.
3. Blajchman, M.A. (2003) Substitutes and alternatives to platelet transfusions in thrombocytopenic patients. Journal of Thrombosis and Haemostasis, 1, 1637 1641.
4. Brenner, B., Hoffman, R., Balashov, D., Shutluko, E., Culic, S.D. Nizamoutdinova, E. (2005) Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII. Clinical and Applied Thrombosis/Hemostasis, 11, 401 410.
5. Butenas, S., Branda, R.F., van't Veer, C., Cawthern, K.M. Mann, K.G. (2001) Platelets and phospholipids in tissue factor-initiated thrombin generation. Thrombosis and Haemostasis, 86, 660 667.
6. Fenger-Eriksen, C., Anker-Moller, E., Heslop, J., Ingerslev, J. Sørensen, B. (2005) Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. British Journal of Anaesthesia, 94, 324 329.
7. Fletcher, C., Pearson, C., Choi, S.C., Duma, R.J., Evans, H.J. Qureshi, G.D. (1986) In vitro comparison of antiplatelet effects of beta-lactam penicillins. Journal of Laboratory and Clinical Medicine, 108, 217 223.
8. George, J.N. (2000) Platelets. Lancet, 355, 1531 1539.
9. Gerotziafas, G.T., Zervas, C., Gavrielidis, G., Tokmaktsis, A., Hatjiharissi, E., Papaioannou, M., Lazaridou, A., Constantinou, N., Samama, M.M. Christakis, J. (2002) Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. American Journal of Hematology, 69, 219 222.
10. Hoffman, M. Monroe, D.M. (2001) A cell-based model of hemostasis. Thrombosis and Haemostasis, 85, 958 965.
11. Ingerslev, J., Poulsen, L.H. Sorensen, B. (2003) Potential role of the dynamic properties of whole blood coagulation in assessment of dosage requirements in haemophilia. Haemophilia, 9, 348 352.
12. Kjalke, M., Ezban, M., Monroe, D.M., Hoffman, M., Roberts, H.R. Hedner, U. (2001) High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system. British Journal of Haematology, 114, 114 120.
13. Kristensen, J., Killander, A., Hippe, E., Helleberg, C., Ellegard, J., Holm, M., Kutti, J., Mellqvist, U.H., Johansson, J.E., Glazer, S. Hedner, U. (1996) Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis, 26 (Suppl. 1 159 164.
14. Lang, T. von Depka, M. (2006) Possibilities and limitations of thrombelastometry/-graphy. Hamostaseologie, 26, S20 S29.
15. Larsen, O.H., Ingerslev, J. Sørensen, B. (2007) Whole blood laboratory model of thrombocytopenia for use in evaluation of hemostatic interventions. Annals of Hematology, 86, 217 221.
16. Luddington, R. Baglin, T. (2004) Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. Journal of Thrombosis and Haemostasis, 2, 1954 1959.
17. Matzdorff, A.C., Kemkes-Matthes, B. Pralle, H. (1998) Reactivity of platelets from healthy individuals and from patients with hematologic diseases following incubation with pegylated recombinant human megakaryocyte growth and development factor in vitro. Haemostasis, 28, 37 44.
18. Persson, E., Kjalke, M. Olsen, O.H. (2001) Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity. Proceedings of the National Academy of Sciences of the United States of America, 98, 13583 13588.
19. Pihusch, M., Bacigalupo, A., Szer, J., von Depka Prondzinski, M., Gaspar-Blaudschun, B., Hyveled, L. Brenner, B. (2005) Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation. Journal of Thrombosis and Haemostasis, 3, 1935 1944.
20. Rivard, G.E., Brummel-Ziedins, K.E., Mann, K.G., Fan, L., Hofer, A. Cohen, E. (2005) Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. Journal of Thrombosis and Haemostasis, 3, 2039 2043.
21. Roberts, H.R., Monroe, D.M. Escobar, M.A. (2004) Current concepts of hemostasis: implications for therapy. Anesthesiology, 100, 722 730.
22. Sallah, S., Husain, A. Nguyen, N.P. (2004) Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation. Blood Coagulation and Fibrinolysis, 15, 577 582.
23. Sørensen, B. Ingerslev, J. (2004a) Thromboelastography and recombinant factor VIIa-hemophilia and beyond. Seminars in Hematology, 41, 140 144.
24. Sørensen, B. Ingerslev, J. (2004b) Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. Journal of Thrombosis and Haemostasis, 2, 102 110.
25. Sørensen, B. Ingerslev, J. (2005) Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography. Haemophilia, 11 (Suppl. 1 1 6.
26. Sørensen, B. Ingerslev, J. (2006) A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate. Thrombosis and Haemostasis, 96, 446 453.
27. Sørensen, B., Johansen, P., Christiansen, K., Woelke, M. Ingerslev, J. (2003a) Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. Journal of Thrombosis and Haemostasis, 1, 551 558.
28. Sørensen, B., Johansen, P., Nielsen, G.L., Sørensen, J.C. Ingerslev, J. (2003b) Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagulation and Fibrinolysis, 14, 469 477.
29. Sørensen, B., Fenger-Eriksen, C. Ingerslev, J. (2005) Recombinant factor VIIa fails to correct coagulopathy induced by haemodilution with colloid. British Journal of Anaesthesia, 94, 862 863.
30. Sørensen, B., Persson, E. Ingerslev, J. (2007) Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A. British Journal of Haematology, 137, 158 165.
31. Toth, O., Calatzis, A., Penz, S., Losonczy, H. Siess, W. (2006) Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thrombosis and Haemostasis, 96, 781 788.
32. Tranholm, M., Rojkjaer, R., Pyke, C., Kristensen, A.T., Klitgaard, B., Lollike, K. Blajchman, M.A. (2003) Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits. Thrombosis Research, 109, 217 223.
33. Velik-Salchner, C., Haas, T., Innerhofer, P., Streif, W., Nussbaumer, W., Klingler, A., Klima, G., Martinowitz, U. Fries, D. (2007) The effect of fibrinogen concentrate on thrombocytopenia. Journal of Thrombosis and Haemostasis, 5, 1019 1025.